AMLODIPINE BESYLATE
| Brand name | NORLIQVA |
|---|---|
| Active ingredient | AMLODIPINE BESYLATE |
| Strength | EQ 1MG BASE/ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2022 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12226528 | February 2041 | product |
| 11458095 | February 2041 | product |
| 12005141 | February 2041 | product |
| 12440441 | February 2041 | product |
| 11723866 | February 2041 | product |
| 11253474 | February 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.